2 Results for "

methyglyoxal

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "methyglyoxal" in MCE Product Catalog:

6
Mitoguazone
Mitoguazone
0 Images
6 Cited Publications
Cat. No.: HY-106634
CAS No.: 459-86-9
Purity:  99.33%
Synonyms: Methylglyoxal-bis(guanylhydrazone); MGBG; Methyl-GAG
Target:  

HIV Apoptosis

Research Areas:  

Infection Cancer

Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbonyl derivative with potent antineoplastic activity. Mitoguazone is a brain-penetrant and competitive S-adenosyl-methionine decarboxylase (SAMDC) inhibitor that disrupts polyamine biosynthesis. Mitoguazone induces cell apoptosis. Mitoguazone inhibits HIV DNA integration into the cellular DNA in both monocytes and macrophages. Mitoguazone has the potential for acute leukemia, Hodgkin's and non-Hodgkin's lymphoma treatment .
Mitoguazone (Standard)
Mitoguazone (Standard)
0 Images
Cat. No.: HY-106634R
CAS No.: 459-86-9
Synonyms: Methylglyoxal-bis(guanylhydrazone) (Standard); MGBG (Standard); Methyl-GAG (Standard)
Target:  

Reference Standards HIV Apoptosis

Research Areas:  

Infection Cancer

Mitoguazone (Standard) is the analytical standard of Mitoguazone. This product is intended for research and analytical applications. Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbonyl derivative with potent antineoplastic activity. Mitoguazone is a brain-penetrant and competitive S-adenosyl-methionine decarboxylase (SAMDC) inhibitor that disrupts polyamine biosynthesis. Mitoguazone induces cell apoptosis. Mitoguazone inhibits HIV DNA integration into the cellular DNA in both monocytes and macrophages. Mitoguazone has the potential for acute leukemia, Hodgkin's and non-Hodgkin's lymphoma treatment .
Assay Types